A Rutgers Health researcher emphasizes the risks associated with unregulated mobile and artificial intelligence (AI) health tools that mislead users regarding substance use reduction. In a commentary for the Journal of the American Medical Association, Jon-Patrick Allem highlights the need for stricter oversight of these applications, which often focus on ad revenue over scientific validation. Many popular apps make unsubstantiated claims about their effectiveness, leaving users vulnerable to misinformation. Consumers can identify evidence-based apps by checking for references to peer-reviewed studies, expert involvement, independent evaluations, and transparency regarding data handling. The current lack of regulation allows misleading apps to proliferate, particularly with the rise of generative AI tools. To safeguard public health, stronger oversight is required, such as FDA approval and clear labeling of evidence-based apps. Ensuring that health tools are accurate and safe is crucial for those managing substance use disorders.
Source link
Share
Read more